FILE PHOTO: A nurse displays a vial of the Comirnaty by BioNTech/Pfizer vaccine against the coronavirus disease (COVID-19) at a vaccination centre in Berlin, Germany, January 1, 2022. REUTERS/Michele Tantussi
FILE PHOTO: A nurse displays a vial of the Comirnaty by BioNTech/Pfizer vaccine against the coronavirus disease (COVID-19) at a vaccination centre in Berlin, Germany, January 1, 2022. REUTERS/Michele Tantussi